Diabetes Board decisions

The Board dismissed the Veteran's motion for revision based on clear and unmistakable error (CUE) in an April 2022 rating decision, as it was not properly raised with the AOJ first.

The Board granted service connection for chronic obstructive pulmonary disease (COPD) and remanded the claims for hypertension and diabetes mellitus.

The Board denied service connection for an acquired psychiatric disorder and diabetes mellitus (DM) as there was no evidence of a current disability, in-service incurrence or aggravation, and no medical nexus to service.

The Board granted service connection for multiple disabilities, including various musculoskeletal conditions and mental health disorders.

The Board remands the claim for service connection for cause of death to ensure an adequate medical opinion is obtained, as the previous opinions were found insufficient.

The Board dismissed the veteran's appeals for an increased rating and service connection due to erroneous docketing of the same issues.

The Board granted service connection for diabetes mellitus, finding that it developed due to obesity secondary to the Veteran's service-connected orthopedic disabilities.

The appeal for service connection for diabetes mellitus was dismissed due to the untimely filing of a VA Form 10182 within one year of the July 2021 rating decision.

The Board granted service connection for various conditions, including neck disability manifested by pain and diabetes mellitus type II, secondary to the Veteran's service-connected bilateral knee degenerative arthritis. The other conditions were also granted as they are caused by the now-service-connected diabetes mellitus type II.

The Board remands the Veteran's claim for an increased evaluation for diabetes mellitus type II, to include separate compensable ratings for diabetic retinopathy, hypertension, hypertensive retinopathy, atrial fibrillation, and stroke residuals.

The Board remands the claims for service connection for diabetes mellitus, type II and hypertension to correct duty to assist errors that occurred prior to the rating decision on appeal.

The Board granted an effective date of March 2, 2023 for heart disease and September 28, 2023 for chronic renal failure, while denying earlier effective dates for PTSD, migraines, diabetes mellitus type II, hypertension, and bilateral hearing loss. The Board also granted a 70 percent evaluation for PTSD.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for tinnitus and denied service connection for hypertension, heart disease, kidney condition, diabetes, left lower extremity neuropathy, left upper extremity neuropathy, right lower extremity neuropathy, right upper extremity neuropathy, depression, and bilateral hearing loss.

The Veteran was granted a 10 percent initial rating for hypertension and special monthly compensation at the rate authorized by 38 U.S.C. § 1114(m), (n), and (r)(1) effective from August 10, 2022, to November 7, 2024.

The Board denied service connection for ischemic heart disease and diabetes mellitus, as well as special monthly compensation based on the need for regular aid and attendance or at the housebound rate.

The Board remands the claims for service connection for diabetes mellitus type II and bilateral lower extremity (BLE) neuropathy to obtain additional private treatment records.

The Board remands the claims for service connection for diabetes mellitus, type II (DMII), hypertension, peripheral vascular disease, bilateral diabetic retinopathy, and bilateral upper and lower diabetic peripheral neuropathy due to insufficient evidence regarding toxic exposures during military service.

The Board remands the matter to obtain additional private treatment records and a VA examination to determine if the Veteran's service-connected PTSD caused or aggravated his death.

The Veteran's claim for a disability evaluation in excess of 60 percent for prostate cancer residuals with voiding dysfunction was denied, while his TDIU claim beginning on August 28, 2015, was granted.